{"title":"药物洗脱支架血管成形术与旁路移植术治疗无保护左主干疾病。","authors":"M. Ramlall, P. Costanzo, A. Ali, J. John","doi":"10.35841/CARDIOLOGY.1.2.31-32","DOIUrl":null,"url":null,"abstract":"Medically treated patients with unprotected left main stem (LMS) coronary artery disease have a poor prognosis and early evidence suggests there is a strong survival benefit from surgical revascularization, especially in patients with left ventricular systolic dysfunction.","PeriodicalId":22442,"journal":{"name":"The Cardiology","volume":"41 1","pages":"31-32"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Angioplasty with drug-eluting stents versus bypass grafting for treatment ofunprotected left main stem disease.\",\"authors\":\"M. Ramlall, P. Costanzo, A. Ali, J. John\",\"doi\":\"10.35841/CARDIOLOGY.1.2.31-32\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Medically treated patients with unprotected left main stem (LMS) coronary artery disease have a poor prognosis and early evidence suggests there is a strong survival benefit from surgical revascularization, especially in patients with left ventricular systolic dysfunction.\",\"PeriodicalId\":22442,\"journal\":{\"name\":\"The Cardiology\",\"volume\":\"41 1\",\"pages\":\"31-32\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35841/CARDIOLOGY.1.2.31-32\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35841/CARDIOLOGY.1.2.31-32","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Angioplasty with drug-eluting stents versus bypass grafting for treatment ofunprotected left main stem disease.
Medically treated patients with unprotected left main stem (LMS) coronary artery disease have a poor prognosis and early evidence suggests there is a strong survival benefit from surgical revascularization, especially in patients with left ventricular systolic dysfunction.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
